Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burtness

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Oncology (Williston Park, N.Y.)|August 25, 2007
Clinical use of monoclonal antibodies to the epidermal growth factor receptor in colorectal cancerBarbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Complexity in the Gastric Cancer Genome and a Biomarker-Driven Trial of Poly (ADP-Ribose) Polymerase Inhibition in Gastric CancerBarbara Burtness
Expert Opinion on Biological Therapy|July 30, 2005
The role of cetuximab in the treatment of squamous cell cancer of the head and neckBarbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neckBarbara Burtness
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Targeted agents: management of dermatologic toxicitiesBarbara Burtness
Expert Opinion on Biological Therapy|June 9, 2007
Her signaling in pancreatic cancerBarbara Burtness
Cancer|October 21, 2017
The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?Barbara Burtness
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
On mentorship: lessons from my fatherBarbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2023
First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer-What Happened?Barbara Burtness
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Commentary: bevacizumab and erlotinib with chemoradiation for head and neck cancerBarbara Burtness
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Oncology (Williston Park, N.Y.)|August 25, 2007
Clinical use of monoclonal antibodies to the epidermal growth factor receptor in colorectal cancerBarbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Complexity in the Gastric Cancer Genome and a Biomarker-Driven Trial of Poly (ADP-Ribose) Polymerase Inhibition in Gastric CancerBarbara Burtness
Expert Opinion on Biological Therapy|July 30, 2005
The role of cetuximab in the treatment of squamous cell cancer of the head and neckBarbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neckBarbara Burtness
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Targeted agents: management of dermatologic toxicitiesBarbara Burtness
Expert Opinion on Biological Therapy|June 9, 2007
Her signaling in pancreatic cancerBarbara Burtness
Cancer|October 21, 2017
The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?Barbara Burtness
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
On mentorship: lessons from my fatherBarbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2023
First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer-What Happened?Barbara Burtness
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Commentary: bevacizumab and erlotinib with chemoradiation for head and neck cancerBarbara Burtness
Pageof 19